Prelude Capital Management’s C4 Therapeutics CCCC Stock Holding History

Prelude Capital Management’s Portfolio CCCC Stock Details CCCC Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$81.4K	Buy
2024 Q1	–	Sell
2023 Q4	$100K	Sell
2023 Q3	$95.1K	Buy
2023 Q2	$93.5K	Buy